Europe's landmark meeting in Gynaecological Oncology, European Society of Gynaecological Oncology (ESGO) 2021, offers professionals a unique opportunity to learn and discuss the latest late-breaking research, new guidelines, practical demonstrations and more.

ESGO 2021

23–25 October 2021 | Prague, Czech Republic

📢And that’s a wrap on #ASCO23! We can go back home full of memories and an online journal full of content for you to catch up on! Visit http://vjoncology.com for our in-person coverage of #ASCO23 today!

@VJOncology @ASCO #ASCO23 #Cancer #OncTwitter #MedTwitter

🎥Today at #ASCO23, we spoke with @PTarantinoMD of @DanaFarber on the results of a population-based study assessing the prognosis and trends in chemo use for patients with stage IA TNBC.

➡️Full interview coming soon to http://VJOncology.com!

@ASCO #BreastCancer #BCSM #TNBC

🎥@RobinL_Jones of @royalmarsdenNHS discusses the INTRIGUE trial findings on ripretinib in patients with GIST at #ASCO2023. Although no PFS or OS improvements overall, patients pretreated with imatinib show OS improvement :

➡️⬅️

@ASCO #UroOnc #UroSoMe

Image for twitter card

Updated overall survival findings from the Phase III INTRIGUE trial

Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, discusses overall survival findings from the Ph...

ow.ly

🎥It was great speaking with Nikolaos Trikalinos, MD, of @WUSTLmed at #ASCO23 on the emerging treatment landscape for patients with advanced extrapulmonary neuroendocrine carcinoma!

Check out http://VJOncology.com for interviews with leading experts from the meeting!

@ASCO

🎥We had the pleasure of speaking to @JSabari of @nyulangone on KRAS-mutated non-small cell #lungcancer earlier this morning at #ASCO23 in Chicago!

📷Watch this space for the interview! http://VJOncology.com

@ASCO

#NSCLC #SCLC #LCSM https://twitter.com/i/web/status/1665753740085714944

Load More

ESGO 2021

23–25 October 2021 | Prague, Czech Republic
Europe's landmark meeting in Gynaecological Oncology, European Society of Gynaecological Oncology (ESGO) 2021, offers professionals a unique opportunity to learn and discuss the latest late-breaking research, new guidelines, practical demonstrations and more.

📢And that’s a wrap on #ASCO23! We can go back home full of memories and an online journal full of content for you to catch up on! Visit http://vjoncology.com for our in-person coverage of #ASCO23 today!

@VJOncology @ASCO #ASCO23 #Cancer #OncTwitter #MedTwitter

🎥Today at #ASCO23, we spoke with @PTarantinoMD of @DanaFarber on the results of a population-based study assessing the prognosis and trends in chemo use for patients with stage IA TNBC.

➡️Full interview coming soon to http://VJOncology.com!

@ASCO #BreastCancer #BCSM #TNBC

🎥@RobinL_Jones of @royalmarsdenNHS discusses the INTRIGUE trial findings on ripretinib in patients with GIST at #ASCO2023. Although no PFS or OS improvements overall, patients pretreated with imatinib show OS improvement :

➡️⬅️

@ASCO #UroOnc #UroSoMe

Image for twitter card

Updated overall survival findings from the Phase III INTRIGUE trial

Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, discusses overall survival findings from the Ph...

ow.ly

🎥It was great speaking with Nikolaos Trikalinos, MD, of @WUSTLmed at #ASCO23 on the emerging treatment landscape for patients with advanced extrapulmonary neuroendocrine carcinoma!

Check out http://VJOncology.com for interviews with leading experts from the meeting!

@ASCO

🎥We had the pleasure of speaking to @JSabari of @nyulangone on KRAS-mutated non-small cell #lungcancer earlier this morning at #ASCO23 in Chicago!

📷Watch this space for the interview! http://VJOncology.com

@ASCO

#NSCLC #SCLC #LCSM https://twitter.com/i/web/status/1665753740085714944

Load More

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter